[PPAR gamma ligand pioglitazone as a therapeutic strategy in nonalcoholic steatohepatitis (NASH)].
Yoneda
Masato
M
yoneda@med.yokohama-cu.ac.jp
Fujita
Koji
K
Nakajima
Atsushi
A
Wada
Koichiro
K
D005234:Fatty Liver / Q000178:diet therapy / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008024:Ligands; D047495:PPAR gamma / Q000378:metabolism*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D008024:Ligands; D047495:PPAR gamma; D045162:Thiazolidinediones; D000077205:Pioglitazone